Sandoz is launching this medicine as an affordable, single-dose, pre-filled syringe alternative to epinephrine auto-injectors. SYMJEPI will be rolled out via a phased launch and will initially be
The post Adamis’ commercial partner launches SYMJEPI in US appeared first on Compelo Medical Devices.
Original Article: Adamis’ commercial partner launches SYMJEPI in US